FdaApplication
NDA 202270
Identifiers
- fda_app_no: NDA202270
Properties
| Property | Value |
|---|---|
| applicant_name | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC |
| application_type | NDA |
| approval_date | 2012-02-02 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JANUMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| JANUMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| JANUMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products